FT US Pharma and Biotech Summit
The FT US Pharma and Biotech Summit will provide a fresh perspective on the crucial issues affecting the pharma and biotech industries.
"
Through the lens of Covid-19 and the industry response to the crisis, the 2nd edition of the FT US Pharma and Biotech Summit will provide a fresh perspective on the crucial issues affecting the pharma and biotech industries. An unrivaled array of senior industry leaders will share their insights, ideas and expertise on topics such as pharma pricing and politics, the expansion of real-world evidence and the opportunities and challenges of unconventional partnerships and collaborations across the new health care landscape.
Confirmed speakers include:
- Stephen M. Hahn, Commissioner, U.S. Food and Drug Administration
- Robert Bradway, Chairman and CEO, Amgen
- Alexander Hardy, Chief Executive Officer, Genentech
- Jessica Mega, Chief Medical and Scientific Officer, Verily
NPC is a supporting partner of this event.
"